Yinxingu Capital

Yinxingu Capital (银杏谷资本) is a Chinese venture capital firm that appears to invest across early-stage rounds, with a pattern of leading or co-leading angel and pre-A financings. Per FreeS Fund's reporting, it co-led Shangyue's RMB 39 million angel round in January 2019 alongside Saiyi Capital, then followed on in the company's RMB 58 million pre-A round later that year . It also led the angel+ round for Mindverse, an AI startup, in 2022 , and was listed among investors in Linguniverse as of late 2025 . The firm's portfolio spans enterprise software, AI, and biotech — it backed Qitan Technology, a nanopore gene sequencing company, in a 2020 round led by Gaorong Ventures , and participated in Dongyi Technology's angel and angel+ rounds for humanoid robotics in 2024-2025 . Elsewhere's corpus does not cover the fund's founding date, AUM, or team background.